Glucotrack corrects warrant exchange shares; 134.8M shares issued for 6.95M warrants

Glucotrack, Inc.

Holders exchanged 6,950,240 Series B Warrants for 134,785,015 common shares from Jan 6-13, 2025.
Remaining 3,079,905 Series B Warrants are exchangeable for about 59,728,158 shares.
Amendment fixes a scrivener's error in the original 8-K regarding issuable shares on remaining warrants.
Warrants allowed cashless exercise for up to 300% of underlying shares; no additional consideration received.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.